Posts by Irina Vainberg
The '156 patent discloses methods of treating and/or preventing metabolic diseases, particularly diabetes, in patients for whom metformin therapy is inappropriate due to intolerability or contraindication …
Irina Vainberg is a partner in the New York office of Troutman Sanders LLP. Her practice is focused on patent prosecution, client counseling and strategic portfolio development, as well as licensing and collaboration agreements in the fields of biotechnology and pharmaceuticals. Her patent experience includes immunology, microbiology, virology, neurobiology, transgenic plant technologies, and pharmaceutical and cosmetic formulations. Irina received her J.D. from Fordham University School of Law and her Ph.D. in cell biology and biochemistry from New York University. For more information, or to contact Irina, please visit her firm profile page.